ESR1 and breast carcinoma: The datasets correspond to biological samples generated from breast cancer patient samples, the estrogen receptor-positive breast cancer cell line ZR-75-1, and the triple-negative breast cancer cell lines MDA-MB-468 and MDA-MB-231.